Skip to content

VisionApp - Refraction and Presbyopia

Assessment of the Accuracy and Repeatability of the VisionApp - Refraction and Presbyopia Measurement Protocol

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07570602
Enrollment
16
Registered
2026-05-06
Start date
2023-07-05
Completion date
2023-07-24
Last updated
2026-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presbyopia, Refractive Errors

Brief summary

Recent Android mobile device technology is available which allows user-measured refractive error and reading add power. This technology could be quite useful to the clinical and research community. The current study aims to evaluate the accuracy, repeatability, and reproducibility of one such technology by VisionApp, specifically with regard to refraction and presbyopia. VisionApp is an app which runs on a smartphone or other device which uses the distance between the user's face and the phone to determine refractive error, while the user looks at different targets (lines, letters, words, etc).

Detailed description

Subjects will be enrolled at the Clinical Optics Research Lab at Indiana University and complete a single study visit. At the study visit, demographic and health/ocular history may be collected by oral history and standard clinical testing including refraction (check of glasses prescription), auto-refraction or aberrometry may be performed. Visual acuity and room lighting checks may also be measured using standard clinical techniques. For the experimental portion of the study visit, the subject will look at a phone running the VisionApp program set at a particular distance (calibration) and then be instructed to move further from, or closer to the phone, until a given target (letter, lines, patterns, etc) are more or less clear. Each test may be repeated until at least 10 good data points are collected. This may be done on the right eye, left eye, or both eyes.

Interventions

DEVICEVisionApp

VisionApp is an app which runs on a smartphone or other device which uses the distance between the user's face and the phone to determine refractive error, while the user looks at different targets (lines, letters, words, etc).

Sponsors

Indiana University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* at least 40 years of age and currently wears a near add correction * has a refractive error between Plano and -5.00 D of sphere and cylinder components combined. * has best corrected visual acuity of at least 20/20 in each eye * is not amblyopic or have any diagnosed ocular disease * is willing and able to follow instructions and maintain the appointment schedule

Exclusion criteria

* has any systemic disease affecting ocular health and visual acuity * is currently using any systemic or topical medications that could affect ocular health and visual acuity * is participating in another eye related research study

Design outcomes

Primary

MeasureTime frameDescription
Spherical Equivalent Refractive ErrorDay 1Spherical equivalent refractive error in diopters will be compared between Myopia Check and traditional refraction.
Near Presbyopic AddDay 1Presbyopic near point in diopters as measured by the VisionApp technique and composite standard clinical measurements.

Countries

United States

Baseline characteristics

Characteristic
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
3 Participants
Age, Categorical
Between 18 and 65 years
13 Participants
Age, Continuous57 years
Region of Enrollment
United States
16 participants
Sex: Female, Male
Female
9 Participants
Sex: Female, Male
Male
7 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 16
other
Total, other adverse events
0 / 16
serious
Total, serious adverse events
0 / 16

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 12, 2026